Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-11-18 00:00:00 ET · period of report 2022-11-16 · accession 0001765581-22-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-18 | 2022-11-16 | JAZZ | Patil Neena M | EVP, CLO | S - Sale | $142.34 | -3,510 | 26.8K | -12% | -$499.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-11-16 | S | D | 3,510 | $142.34 | 26,769 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $142.28 to $142.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |